Triphenyl phosphate enhances adipogenic differentiation, glucose uptake and lipolysis via endocrine and noradrenergic mechanisms

Toxicology in Vitro

Volumn 40, Issue , 2017, Pages 280-288

  Cano Sancho, German ^a   Smith, Anna ^a   La Merrill, Michele A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diabetes mellitus; Diphenyl phosphate; Fatty acids; Firemaster 550; Obesity; Triphenyl phosphate

Indexed keywords

CEBP PROTEIN; CELL PROTEIN; DIPHENYL PHOSPHATE; GLUCOSE TRANSPORTER 4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATE; PHOSPHATIDYLINOSITOL 3 KINASE; TRIPHENYL PHOSPHATE; UNCLASSIFIED DRUG; CCAAT ENHANCER BINDING PROTEIN; CEBPA PROTEIN, MOUSE; FLAME RETARDANT; GLUCOSE; MESSENGER RNA; ORGANOPHOSPHATE; SLC2A4 PROTEIN, MOUSE;

3T3 CELL LINE; ADIPOCYTE; ADIPOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME INHIBITION; FIBROBLAST; GENE EXPRESSION; GLUCOSE TRANSPORT; IN VITRO STUDY; INTRACELLULAR SIGNALING; LIPOLYSIS; 3T3-L1 CELL LINE; ANIMAL; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; MOUSE;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; FLAME RETARDANTS; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; LIPOLYSIS; MICE; ORGANOPHOSPHATES; PPAR GAMMA; RNA, MESSENGER;

EID: 85012097921     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2017.01.021     Document Type: Article

References (45)

1. Amato, A.A., de Assis Rocha Neves, F., Idealized ppargamma-based therapies: lessons from bench and bedside. PPAR Res. 2012 (2012), 978–987.
2. Andresen, J.A., Grundmann, A., Bester, K., Organophosphorus flame retardants and plasticisers in surface waters. Sci. Total Environ. 332 (2004), 155–166.
3. Belcher, S.M., Cookman, C.J., Patisaul, H.B., Stapleton, H.M., In vitro assessment of human nuclear hormone receptor activity and cytotoxicity of the flame retardant mixture fm 550 and its triarylphosphate and brominated components. Toxicol. Lett. 228 (2014), 93–102.
4. Cooper, E.M., Covaci, A., van Nuijs, A.L., Webster, T.F., Stapleton, H.M., Analysis of the flame retardant metabolites bis(1,3-dichloro-2-propyl) phosphate (bdcpp) and diphenyl phosphate (dpp) in urine using liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 401 (2011), 2123–2132.
5. Dodson, R.E., Perovich, L.J., Covaci, A., Van den Eede, N., Ionas, A.C., Dirtu, A.C., et al. After the pbde phase-out: a broad suite of flame retardants in repeat house dust samples from California. Environ. Sci. Technol. 46 (2012), 13056–13066.
6. Dodson, R.E., Van den Eede, N., Covaci, A., Perovich, L.J., Brody, J.G., Rudel, R.A., Urinary biomonitoring of phosphate flame retardants: levels in California adults and recommendations for future studies. Environ. Sci. Technol. 48 (2014), 13625–13633.
7. Felice, D.L., Sun, J., Liu, R.H., A modified methylene blue assay for accurate cell counting. J. Funct. Foods 1 (2009), 109–118.
8. Festuccia, W.T., Laplante, M., Berthiaume, M., Gelinas, Y., Deshaies, Y., Ppargamma agonism increases rat adipose tissue lipolysis, expression of glyceride lipases, and the response of lipolysis to hormonal control. Diabetologia 49 (2006), 2427–2436.
9. Fu, M., Sun, T., Bookout, A.L., Downes, M., Yu, R.T., Evans, R.M., et al. A nuclear receptor atlas: 3t3-l1 adipogenesis. Mol. Endocrinol. (Baltimore, Md) 19 (2005), 2437–2450.
10. Gore, A.C., Chappell, V.A., Fenton, S.E., Flaws, J.A., Nadal, A., Prins, G.S., et al. Edc-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals. Endocr. Rev. 36 (2015), E1–e150.
11. Green, H., Kehinde, O., An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 5 (1975), 19–27.
12. Green, A.J., Graham, J.L., Gonzalez, E.A., La Frano, M.R., Petropoulou, S.E., Park, J.S., et al. Perinatal Triphenyl Phosphate Exposure Accelerates Type 2 Diabetes Onset and Increases Adipose Accumulation in ucd-type 2 Diabetes Mellitus Rats. Reproductive Toxicology. 2016, Elmsford, NY.
13. Grun, F., Blumberg, B., Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 147 (2006), S50–S55.
14. Hwang, J.T., Kim, S.H., Lee, M.S., Kim, S.H., Yang, H.J., Kim, M.J., et al. Anti-obesity effects of ginsenoside rh2 are associated with the activation of ampk signaling pathway in 3t3-l1 adipocyte. Biochem. Biophys. Res. Commun. 364 (2007), 1002–1008.
15. Janesick, A., Blumberg, B., Minireview: ppargamma as the target of obesogens. J. Steroid Biochem. Mol. Biol. 127 (2011), 4–8.
16. Kaur, J., Bachhawat, A.K., A modified western blot protocol for enhanced sensitivity in the detection of a membrane protein. Anal. Biochem. 384 (2009), 348–349.
17. La Merrill, M., Birnbaum, L.S., Childhood obesity and environmental chemicals. Mt. Sinai J. Med., New York 78 (2011), 22–48.
18. Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative pcr and the 2(− delta delta c(t)) method. Methods (San Diego, Calif) 25 (2001), 402–408.
19. McGee, S.P., Konstantinov, A., Stapleton, H.M., Volz, D.C., Aryl phosphate esters within a major pentabde replacement product induce cardiotoxicity in developing zebrafish embryos: potential role of the aryl hydrocarbon receptor. Toxicol. Sci. 133 (2013), 144–156.
20. Meeker, J.D., Stapleton, H.M., House dust concentrations of organophosphate flame retardants in relation to hormone levels and semen quality parameters. Environ. Health Perspect. 118 (2010), 318–323.
21. Meeker, J.D., Cooper, E.M., Stapleton, H.M., Hauser, R., Urinary metabolites of organophosphate flame retardants: temporal variability and correlations with house dust concentrations. Environ. Health Perspect. 121 (2013), 580–585.
22. Mendelsohn, E., Hagopian, A., Hoffman, K., Butt, C.M., Lorenzo, A., Congleton, J., et al. Nail polish as a source of exposure to triphenyl phosphate. Environ. Int. 86 (2016), 45–51.
23. NCD-RisC, Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet (London, England) 387 (2016), 1377–1396.
24. OECD. 2002. Sids Initial Assessment Report: Triphenyl Phosphate. Paris, France.
25. Ogden, C.L., Carroll, M.D., Kit, B.K., Flegal, K.M., Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA 311 (2014), 806–814.
26. Pagliarani, A., Nesci, S., Ventrella, V., Toxicity of organotin compounds: shared and unshared biochemical targets and mechanisms in animal cells. Toxicol. in Vitro 27 (2013), 978–990.
27. Patisaul, H.B., Roberts, S.C., Mabrey, N., McCaffrey, K.A., Gear, R.B., Braun, J., et al. Accumulation and endocrine disrupting effects of the flame retardant mixture firemaster(r) 550 in rats: an exploratory assessment. J. Biochem. Mol. Toxicol. 27 (2013), 124–136.
28. Pereira-Fernandes, A., Vanparys, C., Hectors, T.L., Vergauwen, L., Knapen, D., Jorens, P.G., et al. Unraveling the mode of action of an obesogen: mechanistic analysis of the model obesogen tributyltin in the 3t3-l1 cell line. Mol. Cell. Endocrinol. 370 (2013), 52–64.
29. Pereira-Fernandes, A., Vanparys, C., Vergauwen, L., Knapen, D., Jorens, P.G., Blust, R., Toxicogenomics in the 3t3-l1 cell line, a new approach for screening of obesogenic compounds. Toxicol. Sci. 140 (2014), 352–363.
30. Phuchareon, J., McCormick, F., Eisele, D.W., Tetsu, O., EGFR inhibition evokes innate drug resistance in lung cancer cells by preventing Akt activity and thus inactivating Ets-1 function. Proc. Natl. Acad. Sci. 112 (2015), E3855–E3863.
31. Pillai, H.K., Fang, M., Beglov, D., Kozakov, D., Vajda, S., Stapleton, H.M., et al. Ligand binding and activation of ppargamma by firemaster(r) 550: effects on adipogenesis and osteogenesis in vitro. Environ. Health Perspect. 122 (2014), 1225–1232.
32. Qatanani, M., Lazar, M.A., Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 21 (2007), 1443–1455.
33. Qi, L., Cho, Y.A., Gene-environment interaction and obesity. Nutr. Rev. 66 (2008), 684–694.
34. Regnier, S.M., El-Hashani, E., Kamau, W., Zhang, X., Massad, N.L., Sargis, R.M., Tributyltin differentially promotes development of a phenotypically distinct adipocyte. Obesity (Silver Spring, Md) 23 (2015), 1864–1871.
35. Rosen, E.D., MacDougald, O.A., Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell Biol. 7 (2006), 885–896.
36. Rosen, E.D., Hsu, C.H., Wang, X., Sakai, S., Freeman, M.W., Gonzalez, F.J., et al. C/ebpalpha induces adipogenesis through ppargamma: a unified pathway. Genes Dev. 16 (2002), 22–26.
37. Saltiel, A.R., Kahn, C.R., Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414 (2001), 799–806.
38. Saraf, N., Sharma, P.K., Mondal, S.C., Garg, V.K., Singh, A.K., Role of pparg2 transcription factor in thiazolidinedione-induced insulin sensitization. J. Pharm. Pharmacol. 64 (2012), 161–171.
39. Silventoinen, K., Jelenkovic, A., Sund, R., Hur, Y.M., Yokoyama, Y., Honda, C., et al. Genetic and environmental effects on body mass index from infancy to the onset of adulthood: an individual-based pooled analysis of 45 twin cohorts participating in the collaborative project of development of anthropometrical measures in twins (codatwins) study. Am. J. Clin. Nutr. 104 (2016), 371–379.
40. Su, G., Crump, D., Letcher, R.J., Kennedy, S.W., Rapid in vitro metabolism of the flame retardant triphenyl phosphate and effects on cytotoxicity and mrna expression in chicken embryonic hepatocytes. Environ. Sci. Technol. 48 (2014), 13511–13519.
41. van der Veen, I., de Boer, J., Phosphorus flame retardants: properties, production, environmental occurrence, toxicity and analysis. Chemosphere 88 (2012), 1119–1153.
42. Vishwanath, D., Srinivasan, H., Patil, M.S., Seetarama, S., Agrawal, S.K., Dixit, M.N., et al. Novel method to differentiate 3t3 l1 cells in vitro to produce highly sensitive adipocytes for a glut4 mediated glucose uptake using fluorescent glucose analog. J. Cell Commun. Signal. 7 (2013), 129–140.
43. WHO, Global Status Report on Noncommunicable Diseases 2014. Geneva, Switzerland. 2014.
44. Zebisch, K., Voigt, V., Wabitsch, M., Brandsch, M., Protocol for effective differentiation of 3t3-l1 cells to adipocytes. Anal. Biochem. 425 (2012), 88–90.
45. Zoeller, R.T., Brown, T.R., Doan, L.L., Gore, A.C., Skakkebaek, N.E., Soto, A.M., et al. Endocrine-disrupting chemicals and public health protection: a statement of principles from the endocrine society. Endocrinology 153 (2012), 4097–4110.